The current CBAY market cap is 3.72B. The company's latest EPS is USD -0.9185 and P/E is -35.34.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 31.02M | 0 |
Operating Income | -21.36M | -23.48M | -26.88M | -99k | -32.21M |
Net Income | -24.51M | -26.63M | -28.78M | -808k | -33.88M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 705k | 0 | 0 | 31.07M |
Operating Income | -108.15M | -52.6M | -87.58M | -93.11M | -101.68M |
Net Income | -102.81M | -50.99M | -90M | -106M | -105.37M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 159.25M | 141.85M | 245.32M | 226.65M | 451.05M |
Total Liabilities | 99.07M | 105.7M | 141.13M | 118.24M | 124.86M |
Total Equity | 60.18M | 36.15M | 104.19M | 108.41M | 326.19M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 205.73M | 153.83M | 202.32M | 141.85M | 434.69M |
Total Liabilities | 19.38M | 11.12M | 69.38M | 105.7M | 142.43M |
Total Equity | 186.35M | 142.71M | 132.94M | 36.15M | 292.26M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -65.32M | -84.08M | 6.43M | -19.01M | -45.15M |
Investing | -54.34M | -45.99M | -60.64M | -59.92M | -44.46M |
Financing | 24.55M | 24.55M | 93.07M | 94.12M | 343.04M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -97.91M | -44.73M | -69.43M | -84.08M | -72.53M |
Investing | -34.35M | 47.96M | 48.59M | -45.99M | -86.57M |
Financing | 108.13M | 92k | 118.46M | 24.55M | 345.77M |
Market Cap | 3.72B |
Price to Earnings Ratio | -35.34 |
Price to Sales Ratio | 119.87 |
Price to Cash Ratio | 18.03 |
Price to Book Ratio | 12.74 |
Dividend Yield | - |
Shares Outstanding | 114.72M |
Average Volume (1 week) | 3.34M |
Average Volume (1 Month) | 3.22M |
52 Week Change | 236.37% |
52 Week High | 32.48 |
52 Week Low | 7.2609 |
Spread (Intraday) | 0.08 (0.25%) |
Company Name | Cymabay Therapeutics Inc |
Address |
2711 centerville road wilmington, delaware 19808 |
Website | https://www.cymabay.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.